1.
Lancet
; 403(10431): 1020-1021, 2024 Mar 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38492933
2.
Clin Case Rep
; 11(9): e7901, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37700777
RESUMO
Key Clinical Message: A multidisciplinary team approach, careful hemostasis, and factor replacement therapy are important in the perioperative management of hemophiliac patients undergoing pediatric cardiac surgery. Abstract: The combination of congenital heart diseases (CHD) and hemophilia is rare; furthermore, heart surgery and perioperative management of such cases is challenging. This report illustrates the challenges of pediatric cardiac surgery in an infant with both hemophilia B and CHD. Multidisciplinary team approach, careful hemostasis, and factor replacement therapy were key to success without hemorrhagic complications before, during and after surgery.